CollPlant Biotechnologies Ltd Ordinary Shares (NASDAQ: CLGN) last traded at $0.312, up 4.06% on the session. The quote above updates while this page is open; the figures below are drawn from CollPlant Biotechnologies Ltd Ordinary Shares’s own filings and are restated only when a new one is published.
CollPlant Biotechnologies Ltd Ordinary Shares trades on NASDAQ under the ticker CLGN. Its market capitalisation is $4.00 million.
Valuation measures for CollPlant Biotechnologies Ltd Ordinary Shares, derived from the latest quote and its most recent SEC filing.
| Market cap | $4.00M |
|---|---|
| Enterprise value | $3.11M |
| Price / sales | 1.69 |
| Price / book | 0.66 |
| Beta | 1.29 |
Trailing-twelve-month figures tagged in CollPlant Biotechnologies Ltd Ordinary Shares's XBRL filings with the SEC.
| Revenue (TTM) | $2.37M |
|---|---|
| Net income (TTM) | -$11.49M |
| EPS (TTM) | -$0.940 |
| Gross margin | 64.78% |
| Operating margin | -484.31% |
| Return on equity | -188.93% |
| Cash | $5.59M |
Range and volume for CLGN over the past 52 weeks.
| 52-week high | $3.18 |
|---|---|
| 52-week low | $0.270 |
| Volume | 30.6K |
| Average volume | 59.5K |
| Previous close | $0.300 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.